Lumida
/AEHR
⌘K
Aehr Test Systems

Aehr Test Systems

AEHR
$80.81USD-10.67%-9.65 today

MARKET CAP

2.6B

P/E (TTM)

FWD P/E

DAY RANGE

$81 – $89

52W RANGE

$19
$147

AI Summary

Stalk
TrimMedium

AEHR has failed key support and is trading below all major moving averages with bearish momentum and no signs of exhaustion. Medium-term bias remains bearish under a Stage 3 distribution profile, while short-term conditions lack a clear sell trigger, warranting patience for a pullback into the broken $93–$100 EMA zone for a rejection-based execution. The long-term uptrend above the 200-day SMA remains intact but is secondary to the current downtrend.

  • $22M follow-on order aligns AI revenue mix to over 90% of sales
  • Record Q4 bookings of $60.7M and $100.6M backlog drive FY27 visibility
  • Shares up >500% YTD vs 43% YoY revenue decline highlights stretched valuation
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2018FY 2019FY 2020FY 2021FY 2022TREND
Sales, Adj.$29.6M$21.1M$22.3M$16.6M$50.8M
YoY %+56.4%-28.8%+5.9%-25.5%+206.2%
P / Sales2.0x1.9x1.7x3.5x4.6x
EV / Sales1.8x1.9x1.7x3.9x4.2x
Gross Profit, Adj.$12.4M$7.6M$8.4M$6.0M$23.7M
YoY %+82.7%-38.6%+10.1%-27.9%+292.3%
Margin %41.9%36.1%37.6%36.3%46.6%
EV / Gross Profit4.4x5.2x4.6x10.7x9.0x
EBITDA, Adj.$1.3M$-3.8M$-2.2M$-3.9M$8.1M
YoY %+128.6%-388.6%+43.8%-79.2%+309.4%
Margin %4.5%-18.3%-9.7%-23.3%15.9%
EV / EBITDA40.6x-10.3x-17.8x-16.7x26.2x
EBIT$915,000$-5.0M$-2.8M$-4.2M$7.8M
YoY %+118.6%-646.4%+44.7%-51.2%+286.5%
Margin %3.1%-23.7%-12.4%-25.2%15.3%
EV / EBIT59.1x-7.9x-13.9x-15.4x27.3x
Net Income$528,000$-5.2M$-2.8M$-2.0M$9.4M
YoY %+109.3%-1091.5%+46.5%+27.7%+566.2%
Net Margin1.8%-24.9%-12.6%-12.2%18.6%
EPS (GAAP)$0.02-$0.23-$0.12-$0.09$0.34
YoY %+105.7%-1250.0%+47.8%+25.0%+477.8%